Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Australia's Telix Pharmaceuticals ​said on ‌Monday it has ​agreed to ​acquire Germany-based ITM ⁠Isotope ​Technologies Munich SE ​for about $1.65 billion on a ​cash- ​and debt-free basis.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。